Inceptor Bio Enters into In-licensing Agreement with University of California, Santa Barbara For CAR-M Platform

RALEIGH, N.C.: RALEIGH, N.C., Dec. 16, 2021 /PRNewswire/ -- Inceptor Bio, a Research Triangle Park-based next-generation cell and gene therapy biotechnology company, today announced that it has executed an in-licensing agreement with the University of California, Santa Barbara (UCSB) for an investigational Chimeric Antigen Receptor Macrophage (CAR-M) therapy targeting difficult-to-treat...

Click to view original post